Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Congenital factor XIII deficiency: comprehensive overview of the FranceCoag cohort.
Bouttefroy S, Meunier S, Milien V, Boucekine M, Chamouni P, Desprez D, Harroche A, Hochart A, Thiercelin-Legrand MF, Wibaut B, Chambost H, Rugeri L; CoDeC study group. Bouttefroy S, et al. Among authors: rugeri l. Br J Haematol. 2020 Jan;188(2):317-320. doi: 10.1111/bjh.16133. Epub 2019 Aug 14. Br J Haematol. 2020. PMID: 31414482 Free article. Review.
A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study.
Dargaud Y, Rugeri L, Vergnes MC, Arnuti B, Miranda P, Negrier C, Bestion A, Desmurs-Clavel H, Ninet J, Gaucherand P, Rudigoz RC, Berland M, Champion F, Trzeciak MC. Dargaud Y, et al. Among authors: rugeri l. Br J Haematol. 2009 Jun;145(6):825-35. doi: 10.1111/j.1365-2141.2009.07698.x. Epub 2009 Apr 15. Br J Haematol. 2009. PMID: 19388925 Free article. Clinical Trial.
A Prolonged Treatment Response in Acquired Von Willebrand Syndrome.
Désage S, Le Quellec S, Karlin L, Lienhart A, Meunier S, Rugeri L. Désage S, et al. Among authors: rugeri l. Hamostaseologie. 2019 Nov;39(4):409-412. doi: 10.1055/s-0039-1696960. Epub 2019 Sep 23. Hamostaseologie. 2019. PMID: 31546261
Management of previously untreated patients with severe haemophilia A preferentially treated with recombinant factor VIII products: Two French centres' real-life experience.
Drillaud N, Babuty A, Rugeri L, Fouassier M, Lienhart A, Béné MC, Lefranc C, Ternisien C, Chamouard V, Sigaud M, Pennetier M, Trossaërt M, Meunier S. Drillaud N, et al. Among authors: rugeri l. Haemophilia. 2020 Nov;26(6):e349-e352. doi: 10.1111/hae.14132. Epub 2020 Aug 20. Haemophilia. 2020. PMID: 32815608 No abstract available.
59 results